William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Privia Health Group, Inc (PRVA) Prices 5M Share Secondary Offering at $23.50/sh
-
Biodesix (BDSX) Prices Upsized 30.5M Share Offering at $1.15/sh
-
Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock
-
Privia Health Announces Pricing of Secondary Offering
-
Biodesix Inc. (BDSX) Announces Proposed $30M Stock Offering
-
Biodesix Announces Proposed Public Offering of Common Stock
-
Millennium Trust Names Dan Laszlo Chief Executive Officer
-
Privia Health Group (PRVA) Announces 5M Share Secondary Offering by Selling Stockholders
-
Privia Health Announces Secondary Offering
-
Clarivate (CLVT) gains on new Elliott stake, but change is already taking place
-
Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.
-
Palantir (PLTR) investors missed Fast Radius bankruptcy news - William Blair
-
UPDATE: William Blair Starts Janux Therapeutics (JANX) at Outperform
-
William Blair Downgrades Science 37 (SNCE) to Market Perform
-
William Blair Starts Genmab A/S (GMAB) at Market Perform
-
Dollar plunges as U.S. inflation data spurs exodus from crowded trade
-
New Diversity Accelerator Program Creates Entry-Level Asset Management Jobs
-
Noyo's CEO to Participate at 11th Annual William Blair Benefit Technology Conference
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Sep 30
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Sep 30
-
Investors face unclear outcome in midterms, with questions over spending, regulation
-
Today's most important upgrades
-
Cotton Creek Capital Announces the Sale of Coal City Cob
-
Cotton Creek Capital Announces the Sale of Coal City Cob
-
Orgenesis (ORGS) Secures up to $50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
-
Orgenesis Secures up to $50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
-
Canada's Ritchie Bros to buy auto retailer IAA in $7.3 billion deal
-
Investors still look to LatAm despite political 'pink tide'
-
AssetMark to Participate in Fourth Quarter 2022 Investor Conferences
-
AssetMark to Participate in Fourth Quarter 2022 Investor Conferences
-
Cognizant (CTSH) Hit with Several Downgrades After Weak Results and Guidance
-
UPDATE: William Blair Downgrades Cognizant Technology Solutions (CTSH) to Market Perform
-
Aurora Capital Partners Acquires Leading High Pressure Processing Provider Universal Pure
-
Today's Most Important Downgrades
-
Truelink Capital Acquires Trulite Glass & Aluminum Solutions
-
Olympus Bags a Deal for Liquibox
-
Askeladden Capital Announces Activist Position in MiX Telematics (MIXT)
